ArticleBlood advances2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.
Margaux Soulard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it